Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting is a research paper published in PLoS ONE (2023). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P01 CA100730
National Cancer Institute
Grant: R01 CA216840
US Department of Defense
Grant: BCRP W81XWH16 1-0286
NIH
Grant: 5T32CA113275-07 and 5F32CA189671-02
Children’s Discovery Institute of Washington University
Grant: CDI-CORE-2015-505, CDI-CORE-2019-813
St. Louis Children’s Hospital
Grant: N/A
Foundation for Barnes-Jewish Hospital
Grant: 3770 and 4642
S10
Grant: RR027552
UL1
Grant: TR002345
NCATS NIH HHS
Grant: UL1 TR002345
NCI NIH HHS
Grant: T32 CA113275
NCI NIH HHS
Grant: F32 CA189671
NCRR NIH HHS
Grant: S10 RR027552
FWCI
2.04
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals